Pharmacokinetic modeling of [68Ga]PSMA-11 in primary prostate cancer patients
Le résumé fourni par la source
15 patients underwent a 60-minute dynamic [68Ga]PSMA-11 PET scan (patient 101P had its scan interrupted at 40 min) in list-mode with the field of view over the pelvic area. PET data were reconstructed with a 3D-Ordered-Subsets Expectation Maximization (OSEM) algorithm (3 iteration, 21 subsets, matrix 256x256, 4 mm Gaussian filter) and corrected for decay, scatter and attenuation using Dixon-based MR sequences. The list mode data were reconstructed into 28 frames (10 x 30 s, 5 x 60 s, 5 x 120 s, and 8 x 300 s). Volumes of interest (VOIs) were outlined on the PET images to derive time-activity curves (TACs) in unit Bq/mL. Tumor lesion TACs were derived from VOIs using isocontour threshold of 40% of maximum SUV on late PET images (last 15 min of scan) with the location confirmed on the T2-weighted MR images. Spherical VOIs of 1 mL were outlined on normal prostate and gluteus muscle to derive normal tissue TACs. Arterial blood activity was measured by continuous blood sampling from the radial artery during the first 10 min using an automatic blood sampling device with 1 s temporal resolution. Manual arterial blood samples at 6 time points (approximately 3, 7, 15, 25, 40 and 60 min post-injection). The manual blood samples were immediately put on ice and centrifuged to separate plasma. Whole blood and plasma-activities were measured in a gamma counter. The arterial input function was generated from the blood sampler curve corrected for decay, background and dispersion (15 s), merged with the decay-corrected manual whole blood samples to get a 60-min AIF. This whole-blood AIF was converted into a plasma AIF using the average plasma-to-blood activity ratios from the manual samples for each subject. Included in the data set:- 1 excel file with patient data- 15 text files with blood data xxx_Blood: c_blo: whole-blood TAC, c_inp: plasma TAC (arterial input function)- 14 text files with tissue TACs xxx_TAC (subject 222 did not present any PSMA PET uptake and was excluded from lesion-based analysis): midtime and frame duration in min, uptake data in Bq/mL.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.